A systematic review and meta-analysis of phase III randomized controlled trials to assess the risk of pneumonia, URTIs, and VTE in multiple myeloma patients treated with isatuximab

一项系统评价和荟萃分析，纳入了评估接受伊沙妥昔单抗治疗的多发性骨髓瘤患者发生肺炎、上呼吸道感染和静脉血栓栓塞风险的 III 期随机对照试验。